Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG Vaccine for Pre-Diabetes in Guinea-Bissau
NCT05591339Phase 4Active, not recruiting
- Sponsor
- Bandim Health Project
- Start
- Dec 2023
- Primary completion
- Aug 2027
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in prediabetes comparing BCG vaccine with Placebo (2 arms). Primary endpoints: Hemoglobin A1c at 3 years and Fasting glucose at 3 years. Started Dec 2023; status: active, not recruiting.
02
Drugs
bcg vaccine
03
Conditions
prediabetes
Beyond the preview
Go deeper on NCT05591339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05591339.